Plaintiff no - M s Genentech Inc claimed themselves to be theinnovators of the monoclonal antibody drug Trastuzumab which ismanufactured by the plaintiff no - F Hoffmann-La Roche and is ... beingmarketed in India by plaintiff no - Roche Products India Pvt Ltd under the brand name HERCEPTIN HERCLON and BICELTIS Thedrug Trastuzumab is approved globally for treatment of cancer Thesuit before the Delhi High Court came to be filed seeking to inter aliarestrain respondent No -M s Reliance Life Sciences Pvt Ltd fromlaunching marketing or selling TrastuRel the biosimilar version of theappellants drug Trastuzumab